chr2-28518509-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_153021.5(PLB1):āc.161G>Cā(p.Gly54Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,612,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_153021.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLB1 | NM_153021.5 | c.161G>C | p.Gly54Ala | missense_variant | 3/58 | ENST00000327757.10 | |
PLB1 | NM_001170585.2 | c.161G>C | p.Gly54Ala | missense_variant | 3/57 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLB1 | ENST00000327757.10 | c.161G>C | p.Gly54Ala | missense_variant | 3/58 | 1 | NM_153021.5 | P1 | |
PLB1 | ENST00000422425.6 | c.161G>C | p.Gly54Ala | missense_variant | 3/57 | 1 | |||
PLB1 | ENST00000404858.5 | c.158G>C | p.Gly53Ala | missense_variant | 3/57 | 1 | |||
PLB1 | ENST00000416713.5 | c.-8G>C | 5_prime_UTR_variant | 3/11 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251286Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135802
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1460608Hom.: 0 Cov.: 29 AF XY: 0.0000303 AC XY: 22AN XY: 726710
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 14, 2022 | The c.161G>C (p.G54A) alteration is located in exon 3 (coding exon 3) of the PLB1 gene. This alteration results from a G to C substitution at nucleotide position 161, causing the glycine (G) at amino acid position 54 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at